✦ LIBER ✦

P-485 EGFR mutations do not accurately predict response to erlotinib in first-line monotherapy treatment of advanced non-small-cell lung cancer

✍ Scribed by Giaccone, G.; Janmaat, M.; Gallegos Ruiz, M.; Rodriguez, J.; LeChevalier, T.; Thatcher, N.; Smit, E.; Oulid Alissa, D.; Soria, J.

Book ID: 118573390
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 150 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80978-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-Line Gefitinib in Patients With Ad

First-Line Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR Mutations

✍ Sequist, L. V.; Martins, R. G.; Spigel, D.; Grunberg, S. M.; Spira, A.; Janne, P 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 228 KB

PCN82 Cost-Effectiveness Analysis of Erl

PCN82 Cost-Effectiveness Analysis of Erlotinib Versus Platinum Based Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer EGFR Activating Mutations

✍ P. Garrido; G. López-Vivanco; R. Rosell; B. Espinós; A. Castro-Gomez 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

EGFR mutations are associated with progn

EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer

✍ Wu, Meina; Zhao, Jun; Song, Sonya Wei; Zhuo, Minglei; Wang, Xin; Bai, Hua; Wang, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 268 KB

PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (

PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION TESTING AND FIRST LINE TREATMENT WITH GEFITINIB IS A DOMINANT STRATEGY IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

✍ G. de Lima Lopes 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCN84 COST-EFFECTIVENESS OF ERLOTINIB IN

PCN84 COST-EFFECTIVENESS OF ERLOTINIB IN FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN FIT ELDERLY PATIENTS: AN ECONOMICAL ANALYSIS OF A PROSPECTIVE PHASE 2 STUDY (GFPC 0504)

✍ C Chouaid; H Lecaer; J Crequit; I Monnet; S Chouabe; C Locher; D Paillotin; JB A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB